Transitioning from intramuscular to oral aripiprazole in patients with schizophrenia treated for acute agitation

被引：0
|
作者：
Daniel, D. G. [1 ]
Crandall, D. [1 ]
Manos, G. [1 ]
McQuade, R. D. [1 ]
Gutierrez-Esteinou, R. [1 ]
Pikalov, A. A. [1 ]
Oren, D. A. [1 ]
机构：
[1] Bristol Myers Squibb Co, New York, NY 10154 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S287 / S287
页数：1
相关论文
共 50 条
  • [21] The effectiveness of a single intramuscular injection of aripiprazole in patients with schizophrenia or bipolar disorder, stratified by levels of agitation at baseline
    Zimbroff, D.
    Vester-Blokland, E.
    Manos, G.
    Auby, P.
    Pikalov, A.
    Oren, D. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S276 - S276
  • [22] Intramuscular aripiprazole and lorazepam vs. placebo for agitation in acute mania
    Kostic, D
    Oren, D
    Marcus, R
    Vanveggel, S
    Carson, W
    McQuade, R
    Manos, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S510 - S511
  • [23] Intramuscular aripiprazole versus injectable haloperidol in treatment of acute psychotic agitation
    Istikoglou, C.
    Vlavianou, A.
    Foutsitzis, D.
    Theodortikopoulos, G.
    Polonifis, C.
    Kanellos, P.
    Vlissides, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S469 - S470
  • [24] Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia
    Citrome, Leslie
    Du, Yangchun
    Risinger, Robert
    Stankovic, Srdjan
    Claxton, Amy
    Zummo, Jacqueline
    Bose, Anjana
    Silverman, Bernard L.
    Ehrich, Elliot W.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (02) : 69 - 75
  • [25] Aripiprazole effects in schizophrenia patients with high or low agitation
    West, B
    Appel, J
    Marder, S
    Pultz, J
    Pikalov, A
    Marcus, R
    Gutierrez-Esteinou, R
    Crandall, D
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S261 - S262
  • [26] Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia
    Gonzalez, Domingo
    Bienroth, Markus
    Curtis, Vivienne
    Debenham, Matthew
    Jones, Stuart
    Pitsi, Didier
    George, Mohan
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (03) : 241 - 250
  • [27] Intramuscular aripiprazole - A review of its use in the management of agitation in schizophrenia and bipolar I disorder
    Sanford, Mark
    Scott, Lesley J.
    CNS DRUGS, 2008, 22 (04) : 335 - 352
  • [28] Intramuscular aripiprazole for the treatment of acute agitation accompanied with schizophrenia: Subanalysis of a double-blind controlled study to find the dosage
    Kungel, Martin
    Czaniera, R.
    Ebrecht, M.
    Werner, C.
    Oren, D.
    McQuade, R.
    Modell, S.
    NERVENARZT, 2007, 78 : 77 - 77
  • [29] PALIPERIDONE PALMITATE IN NON-ACUTE BUT SYMPTOMATIC PATIENTS WITH SCHIZOPHRENIA PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ARIPIPRAZOLE
    Hargarter, L.
    Bergmans, P.
    Cherubin, P.
    Rancans, E.
    Bez, Y.
    Parellada, E.
    Carpiniello, B.
    Vidailhet, P.
    Schreiner, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [30] Non-inferiority of intramuscular aripiprazole versus intramuscular haloperidol for the treatment of agitation associated with schizophrenia/schizoaffective disorder
    Oren, D. A.
    Marcus, R. N.
    Manos, G.
    Carson, W. H.
    McQuade, D.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 451 - 451
12345